Drug Topics March 18, 2025
A conversation with Lydia Newsom, PharmD, clinical associate professor of pharmacy practice at Mercer University College of Pharmacy.
Glucagon-like peptide-1 (GLP-1) receptor agonists have become increasingly popular over the last several years. According to a poll from KFF, 1 in 8 American adults reported ever having taken a GLP-1. Although GLP-1s were initially approved to treat type 2 diabetes, they have shown efficacy in several other disease states, including overweight and obesity. One in 5 patients in the KFF poll said they took GLP-1s to treat overweight or obesity.1
According to Lydia Newsom, PharmD, pharmacists are well positioned to help patients who are taking GLP-1s. Aside from dispensing the medication, pharmacists can make sure patients understand proper administration, titration, and...
Today's Sponsors
Today's Sponsor